MICHELLE A FANALE to Bendamustine Hydrochloride
This is a "connection" page, showing publications MICHELLE A FANALE has written about Bendamustine Hydrochloride.
Connection Strength
0.257
-
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes. Ann Oncol. 2016 07; 27(7):1317-23.
Score: 0.130
-
Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity. Br J Haematol. 2016 11; 175(3):531-533.
Score: 0.127